Most People With Cannabis Use Disorder Remain Untreated
.jpg?width=1200)
MONDAY, June 9, 2025 -- Most individuals in the United States with cannabis use disorder (CUD) do not receive treatment, according to a study published online May 19 in Substance Use & Misuse.
Brian D. Graves, Ph.D., from Florida Atlantic University in Boca Raton, and colleagues used national data to examine predictors of receiving CUD treatment and reasons for not receiving treatment across 16 years. The analysis included data from the 2003, 2011, and 2019 National Survey on Drug Use and Health.
The researchers found that across time points, CUD treatment utilization decreased, and most individuals with CUD did not receive treatment. While there were a variety of reasons for not receiving treatment, results suggested that people increasingly did not know where to access treatment, were not ready to stop use, could not afford treatment, and perceived stigma or occupational impact. Consistent predictors of treatment included receiving past-year mental health treatment and community supervision involvement. Significantly lower odds of CUD treatment were seen for Hispanic individuals versus non-Hispanic White individuals in 2003 but not later years. After 2003, prior arrest was significantly associated with two to three times higher odds of receiving CUD treatment.
"Our findings highlight an urgent and growing need for targeted outreach and improved education about available treatment options for CUD," Graves said in a statement. "Achieving access to care requires coordinated, systemic efforts that prioritize the unique challenges faced by varied communities affected by CUD."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
No Adverse Neurodevelopmental Effects Seen From Inhaled Anesthesia in Children Under 2
THURSDAY, Sept. 11, 2025 -- For children younger than 2 years undergoing surgery, no adverse neurodevelopmental effects are seen with the addition of dexmedetomidine and...
Dementia Odds Significantly Increase With More Psychiatric Comorbidities
WEDNESDAY, Sept. 10, 2025 -- Dementia odds significantly increase with the number of psychiatric comorbidities, according to a study published online Sept. 9 in BMJ Mental...
2000 to 2023 Saw Rise in Pediatric Exposure to Medications, Supplements
MONDAY, Sept. 8, 2025 -- From 2000 to 2023, the rate of exposure to medications, dietary supplements, and psychoactive substances increased among children aged 6 to 12 years...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.